HUMHUMANA INC

NYSE humana.com


$ 352.99 $ 0.10 (0.03 %)    

Monday, 26-Aug-2024 15:59:56 EDT
QQQ $ 474.46 $ -4.66 (-0.97 %)
DIA $ 412.48 $ 0.89 (0.22 %)
SPY $ 560.78 $ -1.34 (-0.24 %)
TLT $ 98.13 $ -0.25 (-0.25 %)
GLD $ 232.75 $ 0.74 (0.32 %)
$ 353
$ 354.31
$ 352.80 x 100
-- x --
$ 351.75 - $ 356.15
$ 297.88 - $ 526.87
678,402
na
42.5B
$ 0.90
$ 24.84
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2024 06-30-2024 10-Q
2 04-24-2024 03-31-2024 10-Q
3 02-15-2024 12-31-2023 10-K
4 11-01-2023 09-30-2023 10-Q
5 08-02-2023 06-30-2023 10-Q
6 04-26-2023 03-31-2023 10-Q
7 02-16-2023 12-31-2022 10-K
8 11-02-2022 09-30-2022 10-Q
9 07-27-2022 06-30-2022 10-Q
10 04-27-2022 03-31-2022 10-Q
11 02-17-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 07-28-2021 06-30-2021 10-Q
14 04-28-2021 03-31-2021 10-Q
15 02-18-2021 12-31-2020 10-K
16 11-03-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 04-29-2020 03-31-2020 10-Q
19 02-20-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 07-31-2019 06-30-2019 10-Q
22 05-01-2019 03-31-2019 10-Q
23 02-21-2019 12-31-2018 10-K
24 11-07-2018 09-30-2018 10-Q
25 08-01-2018 06-30-2018 10-Q
26 05-02-2018 03-31-2018 10-Q
27 02-16-2018 12-31-2017 10-K
28 11-08-2017 09-30-2017 10-Q
29 08-02-2017 06-30-2017 10-Q
30 05-03-2017 03-31-2017 10-Q
31 02-17-2017 12-31-2016 10-K
32 11-04-2016 09-30-2016 10-Q
33 08-03-2016 06-30-2016 10-Q
34 05-04-2016 03-31-2016 10-Q
35 02-18-2016 12-31-2015 10-K
36 11-06-2015 09-30-2015 10-Q
37 07-29-2015 06-30-2015 10-Q
38 04-29-2015 03-31-2015 10-Q
39 02-18-2015 12-31-2014 10-K
40 11-07-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 evolent-health-explores-sale-garners-inbound-interest-from-private-equity-firms

Evolent Health is exploring a potential sale, drawing interest from private equity firms like TPG and KKR.

 jp-morgan-maintains-neutral-on-humana-raises-price-target-to-396

JP Morgan analyst Lisa Gill maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $332 to $396.

 whistleblower-lawsuit-against-humana-settles-medicare-part-d-fraud-allegations-for-90m

Humana will pay $90 million to settle a whistleblower lawsuit alleging it overcharged the government by submitting fraudulent M...

 cantor-fitzgerald-reiterates-neutral-on-humana-maintains-395-price-target

Cantor Fitzgerald analyst Sarah James reiterates Humana (NYSE:HUM) with a Neutral and maintains $395 price target.

 deutsche-bank-maintains-hold-on-humana-raises-price-target-to-349

Deutsche Bank analyst George Hill maintains Humana (NYSE:HUM) with a Hold and raises the price target from $341 to $349.

 barclays-maintains-equal-weight-on-humana-lowers-price-target-to-364

Barclays analyst Andrew Mok maintains Humana (NYSE: HUM) with a Equal-Weight and lowers the price target from $370 to $364.B...

 oppenheimer-maintains-outperform-on-humana-raises-price-target-to-400

Oppenheimer analyst Michael Wiederhorn maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $370 t...

 tech-stocks-on-track-for-best-session-in-5-months-ahead-of-fed-meeting-small-caps-target-highest-close-since-january-2022-whats-driving-markets-wednesday

Tech stocks soared to their best session in five months on Wednesday, ahead of the highly anticipated Federal Open Market Commi...

 insurance-giant-humana-stock-tumbles-after-q2-earnings-beat-issues-sub-par-profit-outlook

Humana reports Q2 adjusted EPS of $6.96, surpassing expectations despite a decline from $8.94 last year. Revenue increased to $...

 wall-street-remains-on-track-for-amd-led-rebound-ahead-of-fed-decision-meta-earnings-analyst-says-the-bull-tends-to-remain-despite-near-term-volatility

Tech optimism is likely to abound on Wall Street as AI-levered stocks are feeding off the strength generated by Advanced Micro ...

 humana-q2-2024-adj-eps-696-beats-585-estimate-sales-2938b-beat-2851b-estimate

Humana (NYSE:HUM) reported quarterly earnings of $6.96 per share which beat the analyst consensus estimate of $5.85 by 18.97 pe...

 apple-amazon-microsoft-meta-lead-the-charge-as-investors-bank-on-tech-cheer-for-rallys-reacceleration-week-ahead-in-earnings

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say followin...

Core News & Articles

Builds On Ongoing Collaboration With Google Health To Develop Population Health Solutions And Address Healthcare Challenges

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION